The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global mRNA Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029
Synopsis
The global mRNA Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
This report is a detailed and comprehensive analysis for global mRNA Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global mRNA Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global mRNA Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global mRNA Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global mRNA Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Pfizer, Zydus Cadila, Fosun Pharma and CureVAC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
mRNA Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Preventive Vaccines
Therapeutic Vaccine
Therapeutic Drugs
Market segment by Application
Hospital
Clinic
Major players covered
Moderna
Pfizer
Zydus Cadila
Fosun Pharma
CureVAC
Sri Lankan Microorganisms
BioNtech
AstraZeneca
Janssen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Drug, with price, sales, revenue and global market share of mRNA Drug from 2018 to 2023.
Chapter 3, the mRNA Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and mRNA Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Drug.
Chapter 14 and 15, to describe mRNA Drug sales channel, distributors, customers, research findings and conclusion.
The global mRNA Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
This report is a detailed and comprehensive analysis for global mRNA Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global mRNA Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global mRNA Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global mRNA Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global mRNA Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Pfizer, Zydus Cadila, Fosun Pharma and CureVAC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
mRNA Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Preventive Vaccines
Therapeutic Vaccine
Therapeutic Drugs
Market segment by Application
Hospital
Clinic
Major players covered
Moderna
Pfizer
Zydus Cadila
Fosun Pharma
CureVAC
Sri Lankan Microorganisms
BioNtech
AstraZeneca
Janssen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Drug, with price, sales, revenue and global market share of mRNA Drug from 2018 to 2023.
Chapter 3, the mRNA Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and mRNA Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Drug.
Chapter 14 and 15, to describe mRNA Drug sales channel, distributors, customers, research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of mRNA Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global mRNA Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Preventive Vaccines
1.3.3 Therapeutic Vaccine
1.3.4 Therapeutic Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global mRNA Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global mRNA Drug Market Size & Forecast
1.5.1 Global mRNA Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global mRNA Drug Sales Quantity (2018-2029)
1.5.3 Global mRNA Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business
2.1.3 Moderna mRNA Drug Product and Services
2.1.4 Moderna mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Moderna Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer mRNA Drug Product and Services
2.2.4 Pfizer mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Zydus Cadila
2.3.1 Zydus Cadila Details
2.3.2 Zydus Cadila Major Business
2.3.3 Zydus Cadila mRNA Drug Product and Services
2.3.4 Zydus Cadila mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zydus Cadila Recent Developments/Updates
2.4 Fosun Pharma
2.4.1 Fosun Pharma Details
2.4.2 Fosun Pharma Major Business
2.4.3 Fosun Pharma mRNA Drug Product and Services
2.4.4 Fosun Pharma mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Fosun Pharma Recent Developments/Updates
2.5 CureVAC
2.5.1 CureVAC Details
2.5.2 CureVAC Major Business
2.5.3 CureVAC mRNA Drug Product and Services
2.5.4 CureVAC mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CureVAC Recent Developments/Updates
2.6 Sri Lankan Microorganisms
2.6.1 Sri Lankan Microorganisms Details
2.6.2 Sri Lankan Microorganisms Major Business
2.6.3 Sri Lankan Microorganisms mRNA Drug Product and Services
2.6.4 Sri Lankan Microorganisms mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sri Lankan Microorganisms Recent Developments/Updates
2.7 BioNtech
2.7.1 BioNtech Details
2.7.2 BioNtech Major Business
2.7.3 BioNtech mRNA Drug Product and Services
2.7.4 BioNtech mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 BioNtech Recent Developments/Updates
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca mRNA Drug Product and Services
2.8.4 AstraZeneca mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AstraZeneca Recent Developments/Updates
2.9 Janssen
2.9.1 Janssen Details
2.9.2 Janssen Major Business
2.9.3 Janssen mRNA Drug Product and Services
2.9.4 Janssen mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Janssen Recent Developments/Updates
3 Competitive Environment: mRNA Drug by Manufacturer
3.1 Global mRNA Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global mRNA Drug Revenue by Manufacturer (2018-2023)
3.3 Global mRNA Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of mRNA Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 mRNA Drug Manufacturer Market Share in 2022
3.4.2 Top 6 mRNA Drug Manufacturer Market Share in 2022
3.5 mRNA Drug Market: Overall Company Footprint Analysis
3.5.1 mRNA Drug Market: Region Footprint
3.5.2 mRNA Drug Market: Company Product Type Footprint
3.5.3 mRNA Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global mRNA Drug Market Size by Region
4.1.1 Global mRNA Drug Sales Quantity by Region (2018-2029)
4.1.2 Global mRNA Drug Consumption Value by Region (2018-2029)
4.1.3 Global mRNA Drug Average Price by Region (2018-2029)
4.2 North America mRNA Drug Consumption Value (2018-2029)
4.3 Europe mRNA Drug Consumption Value (2018-2029)
4.4 Asia-Pacific mRNA Drug Consumption Value (2018-2029)
4.5 South America mRNA Drug Consumption Value (2018-2029)
4.6 Middle East and Africa mRNA Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global mRNA Drug Sales Quantity by Type (2018-2029)
5.2 Global mRNA Drug Consumption Value by Type (2018-2029)
5.3 Global mRNA Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global mRNA Drug Sales Quantity by Application (2018-2029)
6.2 Global mRNA Drug Consumption Value by Application (2018-2029)
6.3 Global mRNA Drug Average Price by Application (2018-2029)
7 North America
7.1 North America mRNA Drug Sales Quantity by Type (2018-2029)
7.2 North America mRNA Drug Sales Quantity by Application (2018-2029)
7.3 North America mRNA Drug Market Size by Country
7.3.1 North America mRNA Drug Sales Quantity by Country (2018-2029)
7.3.2 North America mRNA Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe mRNA Drug Sales Quantity by Type (2018-2029)
8.2 Europe mRNA Drug Sales Quantity by Application (2018-2029)
8.3 Europe mRNA Drug Market Size by Country
8.3.1 Europe mRNA Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe mRNA Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific mRNA Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific mRNA Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific mRNA Drug Market Size by Region
9.3.1 Asia-Pacific mRNA Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific mRNA Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America mRNA Drug Sales Quantity by Type (2018-2029)
10.2 South America mRNA Drug Sales Quantity by Application (2018-2029)
10.3 South America mRNA Drug Market Size by Country
10.3.1 South America mRNA Drug Sales Quantity by Country (2018-2029)
10.3.2 South America mRNA Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa mRNA Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa mRNA Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa mRNA Drug Market Size by Country
11.3.1 Middle East & Africa mRNA Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa mRNA Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 mRNA Drug Market Drivers
12.2 mRNA Drug Market Restraints
12.3 mRNA Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of mRNA Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of mRNA Drug
13.3 mRNA Drug Production Process
13.4 mRNA Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 mRNA Drug Typical Distributors
14.3 mRNA Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
